• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

UK Startup Flow Launches Chatbot Therapist to Combat Depression

by Jasmine Pennic 09/27/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
UK Startup Flow Launches Chatbot Therapist to Combat Depression

– UK startup launches Flow, a chatbot therapist engages users with daily chat conversations and offers self-help techniques, mood tracking, curated videos, meditation, and mental exercises.


– Available to download free on iOS, the chatbot therapist is based on the latest psychology and neuroscience research and was developed by clinical psychologists and machine learning experts.


– To maximize the chance of recovery, Flow can be used in conjunction with the Flow brain stimulation headset.


Flow, a London-based medical device company has announced the launch of its chatbot therapist to treat depression. The chatbot therapist, called Flow, engages users with daily chat conversations and offers self-help techniques, mood tracking, curated videos, meditation, and mental exercises. It helps users to learn why sleep, exercise, nutrition, and meditation are the main pillars in recovering from depression – and gathers mood data to offer a personalized response modeled on behavioral therapy. 

Impact of Mental Illness in the UK

Nearly one in four adults in the UK are affected by mental illness. Suicide is the most common cause of death for men aged 20-49 years in England and Wales. The economic costs of mental illness in England is estimated at £105.2 billion annually. And one in three work sickness notes handed out by GPs are for mental health reasons, including depression.

“Accessibility and early intervention in depression is crucial,” says Daniel Mansson, Clinical Psychologist, CEO and Co-Founder of Flow. “The ‘always-on’ source of therapy provided by Flow ensures people get the help they need as quickly as possible. Flow can provide anonymity without the fear of being judged by others. This is great as some people feel anxious when it comes to talking about their depression to another human.”

Brain Stimulation Headset

Flow Launches Medical-Grade Headset, Therapy App for Depression

To maximize the chance of recovery, Flow can be used in conjunction with the Flow brain stimulation headset. Randomized controlled trials published in the New England Journal of Medicine and the British Journal of Psychiatry show that brain stimulation, of the type used in the Flow headset, had a similar impact to antidepressants but with fewer and less-severe side effects.  The Flow headset retails at £399 and can be purchased here.

The brain stimulation headset is the first and only medically approved treatment for depression of its kind in Europe. Classified as a Class IIa medical device, Flow was developed from the fields of clinical psychology, neuroscience and innovative technology including machine learning. Flow empowers and motivates individuals to take control and self-manage their depression with effective, non-pharmacological, digital alternatives.

Flow Availability

Available to download free on iOS, the chatbot therapist is based on the latest psychology and neuroscience research and was developed by clinical psychologists and machine learning experts. An Android version will be available on October 2019. The Flow chatbot therapist requires iOS 11.0 or later. Compatible with iPhone, iPad and iPod touch. Users must be at least 17 years old to download this application

Flow is starting talks with the NHS to have its brain stimulation headset available on prescription. The company recently announced an investment of £1.2 million by Khosla Ventures to roll out it’s offering across Europe, introduce the Flow headset to healthcare clinics in the UK, and fund clinical studies.

The Landscape of Mental Health Chatbots in the UK

Flow joins a growing number of mental health chatbots, including Woebot and Wysa, which are playing an increasing role in the mental health landscape. Whilst Woebot and Wysa use a cognitive behavioral approach to change the way people think, Flow has one goal: to reduce clinical depression based on well-grounded science.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Chatbot in Healthcare, Depression, Depression Mobile Health Apps, Khosla Ventures, Machine Learning, Medical Device, Mental Health, Mental Illness, NHS

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |